Related Experiment Videos
Why do animal models (sometimes) fail to mimic human sepsis?
1Departments of Pathology and Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Critical Care Medicine
|May 1, 2004
Summary
Animal models for sepsis often fail to predict human treatment success due to differences in patient populations and disease progression. Key factors include comorbidities, disease onset, and supportive care, which are not replicated in animal studies.
Area of Science:
- Sepsis research
- Translational medicine
- Pharmacology
Background:
- Animal models are crucial for sepsis research but often show poor translation to human clinical trials.
- Significant discrepancies exist between typical animal models and the complex clinical reality of human sepsis.
Purpose of the Study:
- To explore the underlying reasons for the frequent failure of sepsis drugs in human trials despite success in animal models.
- To identify key differences between animal sepsis models and human sepsis that impact drug efficacy.
Main Methods:
- Literature review using MEDLINE searches to gather information on sepsis research.
- Comparative analysis of methodologies and patient/pathogen characteristics in animal sepsis studies versus human clinical trials.
Main Results:
- Animal models typically use young, healthy subjects with acute sepsis, unlike elderly human patients with comorbidities and slower disease onset.
- Human sepsis patients often receive supportive care (fluids, vasopressors) not used in animal models, complicating drug response assessment.
- Differences in bacterial agents (single vs. mixed infections, antibiotic resistance) and intervention timing (early vs. late stage) further diverge animal and human sepsis.
Conclusions:
- Discrepancies in the causative agents of sepsis and the absence of comorbidities in animal models contribute to the translational gap.
- The timing of intervention and the presence of supportive care in human sepsis significantly differ from animal study designs, impacting drug outcomes.